Market Tracker

11/17 5:15pm ET

Altimmune Inc (NASDAQ:ALT)

2.15
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
2.00
Today|||52-Week Range
14.70
-44.02%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close2.15
Today’s open2.18
Day’s range2.10 - 2.18
Volume85,317
Average volume (3 months)87,660
Market cap$33.7M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
AZRXAzurRx BioPharma Inc0.000.00%
APOPCellect Biotechnolog...0.000.00%
HSGXHistogenics Corp0.000.00%
KMPHKemPharm Inc0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts